Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Evive Biotech aggregated by PharmaCompass.com.

    Client Virtual Booth

    EVIVE BIOTECH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Evive Biotech
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1200 Highway 22 East, Suite 2000, Bridgewater, New Jersey 08807
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.evivebiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/evive-biotech/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Evive Biotech's Biologic Ryzneuta (efbemalenograstim alpha) Receives Approval in the U.S.
    Evive Biotech's Biologic Ryzneuta (efbemalenograstim alpha) Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761134

    FDA
    16 Nov 2023
    Share Share
    Aurobindo unit, Evive Biotech ink licensing pact to commercialise Ryzneuta in US
    Aurobindo unit, Evive Biotech ink licensing pact to commercialise Ryzneuta in US

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-unit-evive-biotech-ink-licensing-pact-to-commercialise-cin-treatment-product-in-us/articleshow/95708321.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    24 Nov 2022
    Share Share
    Evive enters agreement with Acrotech Biopharma to commercialize Ryzneuta in US
    Evive enters agreement with Acrotech Biopharma to commercialize Ryzneuta in US

    https://www.indianpharmapost.com/news/evive-enters-license-agreement-with-acrotech-biopharma-to-commercialize-ryzneuta-in-us-13335

    INDIANPHARMAPOST
    24 Nov 2022
    Share Share
    Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta™
    Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta™

    https://www.prnewswire.com/news-releases/evive-biotech-submits-biologics-license-application-to-us-fda-for-ryzneutatm-301259250.html

    PRNEWSWIRE
    31 Mar 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search